116 related articles for article (PubMed ID: 9129114)
1. An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease.
Yoritaka A; Hattori N; Mori H; Kato K; Mizuno Y
J Neurol Sci; 1997 May; 148(2):181-6. PubMed ID: 9129114
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.
Pearce RK; Owen A; Daniel S; Jenner P; Marsden CD
J Neural Transm (Vienna); 1997; 104(6-7):661-77. PubMed ID: 9444566
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical observation of manganese superoxide dismutase in rat substantia nigra after occlusion of middle cerebral artery.
Liu XH; Kato H; Araki T; Itoyama Y; Kato K; Kogure K
Neurosci Lett; 1994 May; 173(1-2):103-6. PubMed ID: 7936392
[TBL] [Abstract][Full Text] [Related]
4. Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control.
Shimoda-Matsubayashi S; Hattori T; Matsumine H; Shinohara A; Yoritaka A; Mori H; Kondo T; Chiba M; Mizuno Y
Neurology; 1997 Nov; 49(5):1257-62. PubMed ID: 9371904
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka A; Hattori N; Uchida K; Tanaka M; Stadtman ER; Mizuno Y
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2696-701. PubMed ID: 8610103
[TBL] [Abstract][Full Text] [Related]
6. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
Li J; Wang LN; Xiao HL; Li X; Yang JJ
Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.
Zhang J; Perry G; Smith MA; Robertson D; Olson SJ; Graham DG; Montine TJ
Am J Pathol; 1999 May; 154(5):1423-9. PubMed ID: 10329595
[TBL] [Abstract][Full Text] [Related]
8. Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease.
Gai WP; Vickers JC; Blumbergs PC; Blessing WW
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1039-46. PubMed ID: 7916375
[TBL] [Abstract][Full Text] [Related]
9. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
Damier P; Hirsch EC; Agid Y; Graybiel AM
Brain; 1999 Aug; 122 ( Pt 8)():1421-36. PubMed ID: 10430829
[TBL] [Abstract][Full Text] [Related]
10. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease.
Schipper HM; Liberman A; Stopa EG
Exp Neurol; 1998 Mar; 150(1):60-8. PubMed ID: 9514830
[TBL] [Abstract][Full Text] [Related]
11. 17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult.
Tripanichkul W; Sripanichkulchai K; Duce JA; Finkelstein DI
Brain Res; 2007 Aug; 1164():24-31. PubMed ID: 17640623
[TBL] [Abstract][Full Text] [Related]
12. Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrasts with loss in Parkinson's disease.
Tooyama I; McGeer EG; Kawamata T; Kimura H; McGeer PL
Brain Res; 1994 Sep; 656(1):165-8. PubMed ID: 7804831
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease.
Mizuno Y; Matuda S; Yoshino H; Mori H; Hattori N; Ikebe S
Ann Neurol; 1994 Feb; 35(2):204-10. PubMed ID: 8109900
[TBL] [Abstract][Full Text] [Related]
14. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
[TBL] [Abstract][Full Text] [Related]
15. Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study.
Itoh K; Weis S; Mehraein P; Müller-Höcker J
Mov Disord; 1997 Jan; 12(1):9-16. PubMed ID: 8990048
[TBL] [Abstract][Full Text] [Related]
16. Nurr1 in Parkinson's disease and related disorders.
Chu Y; Le W; Kompoliti K; Jankovic J; Mufson EJ; Kordower JH
J Comp Neurol; 2006 Jan; 494(3):495-514. PubMed ID: 16320253
[TBL] [Abstract][Full Text] [Related]
17. Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease.
Shimura-Miura H; Hattori N; Kang D; Miyako K; Nakabeppu Y; Mizuno Y
Ann Neurol; 1999 Dec; 46(6):920-4. PubMed ID: 10589547
[TBL] [Abstract][Full Text] [Related]
18. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.
Ross BM; Mamalias N; Moszczynska A; Rajput AH; Kish SJ
Neuroscience; 2001; 102(4):899-904. PubMed ID: 11182251
[TBL] [Abstract][Full Text] [Related]
19. The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress.
Friedman A; Galazka-Friedman J
Adv Neurol; 2001; 86():137-42. PubMed ID: 11553971
[No Abstract] [Full Text] [Related]
20. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra.
Saggu H; Cooksey J; Dexter D; Wells FR; Lees A; Jenner P; Marsden CD
J Neurochem; 1989 Sep; 53(3):692-7. PubMed ID: 2760616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
